ArticleEndocrine pathology2026
From Tissue Architecture To Genetic Signature: Artificial intelligence-based Analysis of Reticulin Framework and Clinical Variables Predicts Molecular Cluster in Paragangliomas.
Article in Endocrine pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paragangliomas (PGLs), encompassing pheochromocytomas and extra-adrenal paragangliomas, are genetically heterogeneous non-epithelial neuroendocrine neoplasms that segregate into molecular clusters with distinct biological and clinical behavior. Architectural correlates of genotype have not been systematically investigated. This study aimed to assess the reticulin framework as a potential morphologic structural surrogate of molecular background and to introduce a novel deep learning model for its spatially resolved quantitative analysis and genotype prediction. A total of 104 adrenal and extra-adrenal PGLs with complete clinical, pathological, and genetic data were retrospectively analyzed. Reticulin stain was evaluated qualitatively and quantitatively using a supervised convolutional neural network trained on expert-annotated reticulin-stained whole-slide images (WSIs) to map and quantify areas of intact framework and very small nest patterns. Two bias-reduced logistic regression models (Firth’s method) were developed to predict germline cluster 1 genotype, each combining clinical variables (age, tumor size, extra-adrenal presentation) with one artificial intelligence (AI)-derived morphometric feature-percentage of intact framework (Model-INTACT) or very small nests (Model-VSN). PGLs harboring germline cluster 1 variants occurred at a younger age, were larger, more frequently extra-adrenal, and showed significant enrichment of intact reticulin and very small nest patterns compared with cases harboring germline cluster 2 variants and sporadic cases. The supervised AI model accurately mapped and quantified these architectural features across the WSIs. Predictive models integrating AI-derived morphometrics with clinical variables achieved excellent discrimination for germline cluster 1 genotype (AUC 0.981 for Model-INTACT; AUC 0.990 for Model-VSN). Preservation of the reticulin framework, particularly with very small nests, represents a histoarchitectural correlate of pseudohypoxic PGLs. Integration of AI-based morphometric descriptors with clinical parameters enables reliable pre-test prediction of germline cluster 1 genotype, bridging conventional histopathology and molecular classification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.